Author:
Ferrari Myriam,Bosa Luigi,De-Luca Riccardo,Barolo Massimiliano,Zambon Carlo F.,Pengo Vittorio,Padrini Roberto,Bezzo Fabrizio
Reference6 articles.
1. Prediction of warfarin dose: why, when and how?;Eriksson;Pharmacogenomics,2012
2. Use of Pharmacogeneticand Clinical Factors to Predict the Therapeutic Dose of Warfarin;Gage;Clinical Pharmacology and Therapeutics,2008
3. A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy;Hamberg;Clinical Pharmacology and Therapeutics,2007
4. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range;Hirsh;Chest,2001
5. Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis;Jorgensen;PLoS One,2012